Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2012
08/02/2012US20120196928 Red yeast rice extract high in monacolin k content
08/02/2012US20120196927 Prophylactic and/or therapeutic agent for metabolic syndrome
08/02/2012US20120196925 Therapeutic and Diagnostic Molecules
08/02/2012US20120196921 Modulation of sglt-2 expression
08/02/2012US20120196919 Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
08/02/2012US20120196918 PREVENTING ISLET INFLAMMATION AND DYSFUNCTION AND MAINTAINING PROPER GLUCOSE LEVELS BY CONTROLLING eIF5A AND ITS HYPUSINATION
08/02/2012US20120196917 Antidepressant Oral Liquid Compositions
08/02/2012US20120196916 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
08/02/2012US20120196910 Use of azabicyclo hexane derivatives
08/02/2012US20120196906 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase Inhibitors
08/02/2012US20120196903 2-aminooxazolines as taar1 ligands
08/02/2012US20120196902 Sulfoximines as kinase inhibitors
08/02/2012US20120196901 Tertiary amide orexin receptor antagonists
08/02/2012US20120196899 Methods and products for treating inflammation
08/02/2012US20120196865 Acyl Guanidine Derivatives Modulating The Hedgehog Protein Signaling Pathway
08/02/2012US20120196863 1,4 oxazines as bace1 and/or bace2 inhibitors
08/02/2012US20120196862 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196861 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196857 Modulators of Muscarinic Receptors
08/02/2012US20120196853 Novel Quinoline-Hepcidine Antagonists
08/02/2012US20120196848 Thienooxazepine derivative
08/02/2012US20120196844 Compounds and compositions as modulators of gpr119 activity
08/02/2012US20120196837 Method of treating frailty
08/02/2012US20120196831 COMPOSITION FOR TREATING AND PREVENTING OBESITY INCLUDING HIGH WATER-SOLUBLE 2-HYDROXYPROPYL-betaCYCLODEXTRIN AS EFFECTIVE COMPONENT
08/02/2012US20120196829 Method of using beta-hydroxy-beta-methylbutyrate for the prevention and treatment of disease conditions
08/02/2012US20120196817 Method for enhancing nutrient absorption with astragalosides
08/02/2012US20120196816 Method for enhancing nutrient absorption with astragalosides
08/02/2012US20120196813 Glycoside derivative and uses thereof
08/02/2012US20120196812 Pharmaceutical composition, methods for treating and uses thereof
08/02/2012US20120196804 Glucagon analogs exhibiting physiological solubility and stability
08/02/2012US20120196802 Modified exendins and uses thereof
08/02/2012US20120196799 Amylin Family Peptides and Methods for Making and Using Them
08/02/2012US20120196798 Glp-1 analogues and their pharmaceutical salts and uses
08/02/2012US20120196797 Methods and Compositions for the Treatment of Gastrointestinal Disorders
08/02/2012US20120196796 Amylin family peptides and methods for making and using them
08/02/2012US20120196795 Novel exendin variant and conjugate thereof
08/02/2012US20120196057 Combination of vitamin d and 25-hydroxyvitamin d 3
08/02/2012US20120195990 Composition to enhanced HDL cholesterol and to decrease intima-media thickening in animals and humans and a method for its preparation
08/02/2012US20120195964 Phosphate-binding magnesium salts and uses thereof
08/02/2012US20120195954 Method of Reducing Appetite
08/02/2012US20120195934 Polymeric gel delivery system for pharmaceuticals
08/02/2012US20120195933 Pharmaceutical compositions comprising tasocitinib
08/02/2012US20120195929 Compounds that modulate autoimmunity and methods of using the same
08/02/2012US20120195902 Compositions and methods for treating renal disease
08/02/2012US20120195901 Compositions and Methods for Binding Lysophosphatidic Acid
08/02/2012US20120195896 Igf-1 fusion polypeptides and therapeutic uses thereof
08/02/2012US20120195883 Monocot seed product comprising a human blood protein
08/02/2012US20120195881 Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions and their use
08/02/2012US20120195868 Nutritional compositions comprising fiber and probiotics
08/02/2012US20120195864 Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof
08/02/2012CA2825858A1 Phosphorus-containing group-substituted quinoline, its preparation process, medical composition containing the compound and application
08/02/2012CA2825845A1 Process for preparation of a herbal extract
08/02/2012CA2825778A1 Pharmaceutical compositions comprising human antibodies to pcsk9
08/02/2012CA2825683A1 Leptin derivatives
08/02/2012CA2825408A1 Tetrazole compounds and methods of making and using same
08/02/2012CA2825157A1 Therapeutic or preventive agent for diabetes
08/02/2012CA2825098A1 Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
08/02/2012CA2823804A1 Novel tetrahydroquinoline derivatives
08/01/2012EP2481726A2 Crystal forms of saxagliptin and processes for preparing same
08/01/2012EP2481408A2 New use of glutaminyl cyclase inhibitors
08/01/2012EP2481298A2 Use of plant extracts as prebiotics, compostions and foods containing such extracts
08/01/2012EP2480667A1 Modulation of ttc39 expression to increase hdl
08/01/2012EP2480551A1 Gpr 119 modulators
08/01/2012EP2480549A1 Fused imidazo [3, 2 - d]pyrazines as pi3 kinase inhibitors
08/01/2012EP2480545A1 Fused triazole amines as p2x7 modulators
08/01/2012EP2480536A2 Toll-like receptor modulators and uses thereof
08/01/2012EP2480532A1 Piperidine derivatives and their use to treat obesity, diabetes, dyslipidemia and atherosclerosis
08/01/2012EP2480530A1 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia
08/01/2012EP2480254A2 Insulin receptor binding antibodies
08/01/2012EP2480246A2 Composition and method for treatment of diabetes
08/01/2012EP2297166B1 Substituted n-imidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
08/01/2012EP2262770B1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
08/01/2012EP2173750B1 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
08/01/2012EP2142552B1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
08/01/2012EP2067479B1 A hypolipidemic composition and its use
08/01/2012EP2024347B1 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
08/01/2012EP1846415B1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
08/01/2012EP1794159B1 7-azaindoles and their use as ppar agonists
08/01/2012EP1666472B1 Phenylacetic acid derivative, process for producing the same, and use
08/01/2012EP1425000B1 Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity
08/01/2012EP1328653B1 Highly expressible genes
08/01/2012CN1534010B Water soluble extract of red sage root and its preparation method and use
08/01/2012CN102625804A Compounds useful for treating AIDS
08/01/2012CN102625705A A plant extract comprising statins and preparation techniques and uses thereof
08/01/2012CN102618420A Health-care liquor and manufacturing method thereof
08/01/2012CN102618413A Production method of traditional Chinese medicine alcoholic drink
08/01/2012CN102617745A Preparation method and blood sugar lowering function of Ganoderma lucidum karst polysaccharide F31
08/01/2012CN102617706A Methods for preventing mitochondrial permeability transition
08/01/2012CN102617690A Vitamin d derivatives
08/01/2012CN102617596A Dimeric sesquiterpene compound Hippolide I, its preparation method and its purpose
08/01/2012CN102617580A Vasopressin V1a Antagonists
08/01/2012CN102617578A Imidazole derivative and medicine application thereof
08/01/2012CN102617566A Pyrazolo alkylimidazole derivative
08/01/2012CN102617564A Compound and preparation method thereof
08/01/2012CN102617563A Compound and preparation method thereof
08/01/2012CN102617556A Novel 2-heteroaryl substituted benzothiophenes and benzofuranes 709
08/01/2012CN102617548A Bicycloheteroaryl compounds as GPR Receptor stimulant, compositions and application thereof
08/01/2012CN102617533A Compound separated from red yeast rice, its preparation method and application
08/01/2012CN102614512A Multiple-variable dose regimen for treating TNFalpha-related disorders
08/01/2012CN102614498A Insulin nanoparticle and preparation method thereof
1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 1298